Clinical Trials
4 trialsNCT04922658 2024-07-31
Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2 Unknown
NCT05978401 2023-08-07
Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer
Guangzhou Gloria Biosciences Co., Ltd.
Phase 1/2 Unknown
NCT05287386 2022-03-18
A Single-Arm Phase II Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy
The First Affiliated Hospital of Xiamen University
Phase 2 Unknown
NCT00786331 2009-08-03
Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2 Unknown